SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+8.18%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$235M
AUM Growth
+$235M
(+4.8%)
Cap. Flow
-$666K
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
51.02%
Holding
47
New
7
Increased
8
Reduced
13
Closed
11
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$29.6M |
| 2 |
Abbott
ABT
|
$6.84M |
| 3 |
Medtronic
MDT
|
$5.4M |
| 4 |
Revvity
RVTY
|
$5.11M |
| 5 |
Zimmer Biomet
ZBH
|
$4.32M |
Top Sells
| 1 |
Merck
MRK
|
$8.16M |
| 2 |
Thermo Fisher Scientific
TMO
|
$7.74M |
| 3 |
Biogen
BIIB
|
$6.96M |
| 4 |
ResMed
RMD
|
$5.74M |
| 5 |
Edwards Lifesciences
EW
|
$5.54M |
Sector Composition
| 1 | Healthcare | 87.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $29.6M | 12.55% | +300,000 | New | +$29.6M |
|
2
Eli Lilly
LLY
$657B
| $12.8M | 5.44% | 14,500 -500 | -3% | -$443K |
|
3
Tenet Healthcare
THC
$16.3B
| $10.8M | 4.57% | 65,000 -5,000 | -7% | -$831K |
|
4
Novo Nordisk
NVO
$251B
| $10.7M | 4.54% | 90,000 | – | – |
|
5
Universal Health Services
UHS
$11.6B
| $10.3M | 4.36% | 45,000 +5,000 | +13% | +$1.15M |
|
6
McKesson
MCK
$85.4B
| $9.89M | 4.19% | 20,000 +2,000 | +11% | +$989K |
|
7
Stryker
SYK
$150B
| $9.75M | 4.13% | 27,000 +2,000 | +8% | +$723K |
|
8
Boston Scientific
BSX
$156B
| $8.8M | 3.73% | 105,000 -10,000 | -9% | -$838K |
|
9
Intuitive Surgical
ISRG
$170B
| $8.6M | 3.64% | 17,500 | – | – |
|
10
Danaher
DHR
$147B
| $8.34M | 3.53% | 30,000 | – | – |
|
11
HCA Healthcare
HCA
$94.5B
| $8.13M | 3.44% | 20,000 -5,000 | -20% | -$2.03M |
|
12
Surgery Partners
SGRY
$2.91B
| $7.42M | 3.14% | 230,000 -20,000 | -8% | -$645K |
|
13
Acadia Healthcare
ACHC
$2.12B
| $7.29M | 3.09% | 115,000 +34,997 | +44% | +$2.22M |
|
|
14
Abbott
ABT
$231B
| $6.84M | 2.9% | +60,000 | New | +$6.84M |
|
15
Avantor
AVTR
$9.18B
| $6.47M | 2.74% | 250,000 | – | – |
|
16
Becton Dickinson
BDX
$55.3B
| $6.03M | 2.55% | 25,000 | – | – |
|
17
Baxter International
BAX
$12.7B
| $5.7M | 2.41% | 150,000 +50,000 | +50% | +$1.9M |
|
18
Cencora
COR
$56.5B
| $5.63M | 2.38% | 25,000 -1,000 | -4% | -$225K |
|
|
19
Medtronic
MDT
$119B
| $5.4M | 2.29% | +60,000 | New | +$5.4M |
|
|
20
Revvity
RVTY
$10.5B
| $5.11M | 2.16% | +40,000 | New | +$5.11M |
|
21
West Pharmaceutical
WST
$17.8B
| $5.1M | 2.16% | 17,000 +4,000 | +31% | +$1.2M |
|
22
Cardinal Health
CAH
$35.5B
| $4.97M | 2.11% | 45,000 -15,000 | -25% | -$1.66M |
|
23
Select Medical
SEM
$1.61B
| $4.88M | 2.07% | 140,000 -5,000 | -3% | -$174K |
|
24
Encompass Health
EHC
$12.3B
| $4.83M | 2.05% | 50,000 -5,000 | -9% | -$483K |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $4.65M | 1.97% | 10,000 -5,000 | -33% | -$2.33M |
|